Trial Profile
Effect of single dose i.v. iron supplementation on whole-genome transcription in patients with chronic kidney graft failure
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Sep 2016
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Pharmacodynamics; Pharmacogenomic
- 08 Sep 2016 New trial record